Application of Machine Learning Based Approaches in Emergency Department to Support Clinical Decision Managing SARS-CoV-2 Infected Patients
1 other identifier
observational
779
1 country
1
Brief Summary
The aim of the study is to develop a prognostic prediction model based on machine learning algorithms in patients affected by coronavirus disease 2019 (COVID-19), the prediction model will be capable to recognize patient with favorable prognosis or patient with poor prognosis by intelligent systems data analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 27, 2020
CompletedFirst Submitted
Initial submission to the registry
March 29, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedFebruary 24, 2022
September 1, 2021
2.1 years
March 29, 2021
February 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
COVID-19 clinical course
Data about sex, age, symptoms start date, symptoms, comorbidity, vital parameters, hematochemical blood tests, therapy, oxygen support, radiology, clinical disease progression will be collected. The collected data will be analyzed through a machine learning based approach to predict the prognosis of patients affected by COVID-19.
2 months
Secondary Outcomes (1)
Application of machine learning algorithms on data of patients affected by COVID-19
2 months
Study Arms (2)
training cohort
data collection
validation cohort
data collection
Eligibility Criteria
Italian caucasian patients aged over 18 years old SARS-CoV-2 infection confirmed by PCR
You may qualify if:
- patients aged over 18 positive for COVID-19 by polymerase chain reaction assay for rhino-pharyngeal swab
You may not qualify if:
- Under 18 aged
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of L'Aquila
L’Aquila, 67100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
March 29, 2021
First Posted
April 1, 2021
Study Start
February 27, 2020
Primary Completion
March 30, 2022
Study Completion
April 30, 2022
Last Updated
February 24, 2022
Record last verified: 2021-09